What is the recommended treatment for acute bacterial tonsillitis?

Treatment of Acute Bacterial Tonsillitis

For acute bacterial tonsillitis caused by Group A Streptococcus (GAS), penicillin V or amoxicillin for 10 days is the first-line treatment, with narrow-spectrum cephalosporins, clindamycin, or macrolides reserved for penicillin-allergic patients. 1

First-Line Antibiotic Therapy

The Infectious Diseases Society of America (IDSA) provides clear, evidence-based recommendations with strong, high-quality evidence supporting penicillin-based regimens 1:

For Penicillin-Tolerant Patients:

• Penicillin V (oral):

  • Children: 250 mg twice or three times daily
  • Adolescents/adults: 250 mg four times daily OR 500 mg twice daily
  • Duration: 10 days (strong, high evidence)

• Amoxicillin (oral) - equally effective alternative:

  • 50 mg/kg once daily (max 1000 mg) OR 25 mg/kg twice daily (max 500 mg/dose)
  • Duration: 10 days (strong, high evidence)

• Benzathine penicillin G (intramuscular) - single-dose option:

  • <27 kg: 600,000 units
  • ≥27 kg: 1,200,000 units
  • Single injection (strong, high evidence)

For Penicillin-Allergic Patients:

First-tier alternatives (avoid cephalosporins if immediate-type hypersensitivity):

• Cephalexin: 20 mg/kg/dose twice daily (max 500 mg/dose) for 10 days (strong, high)
• Cefadroxil: 30 mg/kg once daily (max 1 g) for 10 days (strong, high)

For true penicillin allergy:

• Clindamycin: 7 mg/kg/dose three times daily (max 300 mg/dose) for 10 days (strong, moderate)
• Azithromycin: 12 mg/kg once daily (max 500 mg) for 5 days (strong, moderate)
• Clarithromycin: 7.5 mg/kg/dose twice daily (max 250 mg/dose) for 10 days (strong, moderate)

Critical Treatment Principles

The 10-day duration is non-negotiable for penicillin-based therapy 1. This duration is specifically proven to prevent acute rheumatic fever and glomerulonephritis—the primary reason for treating GAS pharyngitis beyond symptom relief. While shorter courses may improve symptoms, only the full 10-day course has demonstrated efficacy in preventing these serious nonsuppurative complications 2.

Why penicillin remains first-line: Penicillin has never developed resistance in GAS, has a narrow spectrum (reducing collateral damage to normal flora), is cost-effective, and has decades of proven efficacy 1, 3. The American Heart Association reinforces this recommendation specifically for rheumatic fever prevention 3.

Symptomatic Management

Analgesics are essential adjunctive therapy:

• NSAIDs (ibuprofen) and/or acetaminophen for pain control 1, 2
• Topical anesthetics (lozenges with benzocaine, lidocaine sprays) provide temporary relief but avoid in young children due to choking risk 1

Corticosteroids are NOT recommended despite reducing pain duration by approximately 5 hours, given the self-limited nature of GAS pharyngitis, efficacy of antibiotics and analgesics, and potential adverse effects of systemic steroids 1.

Important Clinical Caveats

Macrolide Resistance Warning

Resistance of GAS to azithromycin and clarithromycin varies geographically and temporally 1. These should only be used when penicillin allergy is documented, not as convenience alternatives for shorter courses.

Carrier State vs. Active Infection

Approximately 20% of school-age children are asymptomatic GAS carriers 1. Carriers do NOT require treatment as they:

• Are unlikely to spread infection to contacts
• Have minimal to no risk of suppurative or nonsuppurative complications
• Are experiencing viral pharyngitis with incidental GAS colonization

If treating recurrent episodes, consider whether the patient is a carrier with intercurrent viral infections rather than true recurrent bacterial tonsillitis 1.

When NOT to Treat

Do not prescribe antibiotics for:

• Low-risk patients (Centor/McIsaac score <3) without confirmatory testing 4
• Viral pharyngitis (70-95% of cases) 5, 6
• Asymptomatic GAS carriers 1

Goals of Treatment

Treatment aims to 1, 3:

1. Prevent acute rheumatic fever (primary goal from morbidity/mortality standpoint)
2. Prevent suppurative complications (peritonsillar abscess, cervical lymphadenitis, mastoiditis)
3. Reduce symptom duration and severity
4. Decrease contagiousness and transmission
5. Prevent acute glomerulonephritis

The prevention of rheumatic fever—though rare in high-income countries (0.5 per 100,000 school-age children)—remains the cornerstone justification for antibiotic treatment, as this can cause permanent cardiac damage affecting quality of life and mortality 2.